Skip to main content

Find Clinical Trials

Home
Conditions
Parotid Diseases

Clinical trial condition

Parotid Diseases

Explore clinical trials studying Parotid Diseases. Study availability and eligibility vary by location and protocol.

85 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Parotid Diseases trial results

Completed

Safety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy Toddlers

NCT00626327

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Chickenpox, +26 more
Locations: Site 85 - Birmingham Pediatric Associates, 806 St. Vincent's Drive Birmingham, Alabama, United States

Site 86 - Southeastern Pediatrics Associate, 364 Honeysuckle Road Dothan, Alabama, United States

Site 00 - Veritas Research LLC/ Stabler Clinic, 300 North College Street, Greenville, Alabama, United States

Site 42 - Drug Research and Analysis Corporation, 1758 Parkplace, Suite 200 Montgomery, Alabama, United States

View all 90 locations

View Trial Details

Completed

The Use of Human Acellular Dermal Matrix to Improve Infraauricular Depressed Deformities and Frey's Syndrome

NCT01414790

Conditions: Head and Neck Neoplasms, Mouth Diseases, Mouth Neoplasms, +8 more
Locations: West China Hospital of Stomatology Chengdu, Sichuan, China

View Trial Details

Completed

Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes

NCT00351923

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Bönnigheim, Baden-Wurttemberg, Germany

GSK Investigational Site Bretten, Baden-Wurttemberg, Germany

GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany

GSK Investigational Site Karlsruhe, Baden-Wurttemberg, Germany

View all 20 locations

View Trial Details

Active, Not Recruiting

A Phase 1 Trial of Intranasal Mumps Virus Vaccines in Healthy Adults

NCT06967181

Conditions: Infections, Mononegavirales Infections, Mouth Diseases, +9 more
Locations: University Of Rochester Medical Center Rochester, New York, United States

Cincinnati Children's Hospital Medical Center Vaccine Research Center Cincinnati, Ohio, United States

Coastal Carolina Research Center North Charleston, South Carolina, United States

View Trial Details

Active, Not Recruiting

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

NCT02628067

Conditions: Adenocarcinoma, Adenoma, Advanced Cancer, +88 more
Locations: Not specified

View Trial Details